A detailed history of Westwood Holdings Group Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Westwood Holdings Group Inc holds 44,982 shares of CRSP stock, worth $2.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
44,982
Previous 37,375 20.35%
Holding current value
$2.15 Million
Previous $2.02 Million 4.71%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$44.62 - $62.75 $339,424 - $477,339
7,607 Added 20.35%
44,982 $2.11 Million
Q2 2024

Aug 13, 2024

BUY
$51.17 - $68.18 $1.15 Million - $1.54 Million
22,516 Added 151.53%
37,375 $2.02 Million
Q1 2024

May 14, 2024

SELL
$60.67 - $89.12 $1.85 Million - $2.72 Million
-30,473 Reduced 67.22%
14,859 $1.01 Million
Q4 2023

Feb 13, 2024

SELL
$38.62 - $72.18 $5.02 Million - $9.37 Million
-129,856 Reduced 74.12%
45,332 $2.84 Million
Q3 2023

Nov 14, 2023

BUY
$45.39 - $59.0 $3.87 Million - $5.02 Million
85,158 Added 94.59%
175,188 $7.95 Million
Q2 2023

Aug 11, 2023

SELL
$43.47 - $67.77 $152,536 - $237,804
-3,509 Reduced 3.75%
90,030 $5.05 Million
Q1 2023

May 12, 2023

BUY
$41.0 - $56.12 $2.6 Million - $3.56 Million
63,360 Added 209.95%
93,539 $4.23 Million
Q4 2022

Feb 14, 2023

SELL
$39.19 - $65.67 $84,258 - $141,190
-2,150 Reduced 6.65%
30,179 $1.23 Million
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $607,639 - $833,192
-9,945 Reduced 23.53%
32,329 $2.11 Million
Q2 2022

Aug 15, 2022

BUY
$43.23 - $73.83 $1.02 Million - $1.74 Million
23,582 Added 126.16%
42,274 $2.57 Million
Q1 2022

May 12, 2022

BUY
$53.19 - $79.24 $502,060 - $747,946
9,439 Added 102.01%
18,692 $1.17 Million
Q4 2021

Feb 25, 2022

SELL
$70.09 - $111.29 $703,703 - $1.12 Million
-10,040 Reduced 52.04%
9,253 $701,000
Q3 2021

Nov 12, 2021

BUY
$110.2 - $156.64 $1.03 Million - $1.46 Million
9,310 Added 93.26%
19,293 $2.16 Million
Q2 2021

Aug 16, 2021

BUY
$100.84 - $161.89 $1.01 Million - $1.62 Million
9,983 New
9,983 $1.62 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Westwood Holdings Group Inc Portfolio

Follow Westwood Holdings Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.